Peter Grant

Biography

  Peter Grant is a founder director of Fusion IP PLC, an AIM listed company involved in commercialising university-based research. Peter is also a non-executive director of Adjuvantix Limited and Asterion Limited, all companies acting in the field of human healthcare. Following his PhD, Peter joined Genzyme UK as a Senior Research Scientist working within the clinical diagnostics division. He moved to Celltech from Genzyme, and was then recruited by Sir Christopher Evans to join the start-up team at Enzymatix Limited where he became the Head of R&D, spanning five business areas. Two of these were later spun out to form Chiros (later Chiroscience) and Celsis with Peter as a co-founder and R&D Director. Following venture capital funding rounds Celsis was successfully floated on the London Stock Exchange in June 1993. Peter completed his tenure at Celsis as Director of Business Development and Technology leaving in 2002 to set up Fusion IP PLC.

Research Interest